Cee Chrvcore

7 Flips | 1 Magazine | 157 Likes | 3 Following | @CeeChrvcore | Keep up with Cee Chrvcore on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Cee Chrvcore”

Cancer Patients Get Little Guidance From Doctors On Using Medical Marijuana

<b>Please</b> <b>sign up here</b> <b>to get occasional updates from WBUR's ongoing series, "This Moment in Cancer."</b><p>Even three queasy pregnancies didn't prepare Kate Murphy for the nonstop nausea that often comes with chemotherapy.<p>In the early months of 2016, the Lexington, Mass., mother tried everything the doctors …

New cancer treatments have perplexing side effects

By Laurie McGinley<p>, Reporter<p>When Diane Legg began seeing black specks in her right eye, she went to an ophthalmologist near her home in Amesbury, Mass. He said she had a torn retina and needed laser surgery.<p>Legg's oncologist was skeptical. He was worried that Legg had eye inflammation, called …

New Compound Restores Immune Response in Patients with Melanoma

<b>Lugano, Switzerland (Scicasts)</b> - A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO …

Immunotherapy

Could targeting this gene stop melanoma from spreading?

New research has uncovered a gene responsible for creating a protein that may help melanoma to grow and spread. Targeting this protein may change …

Idera Pharma's IMO-2125 Fast Track'd for treatment-resistant melanoma; shares ahead 9% premarket

Idera Pharmaceuticals (NASDAQ:IDRA) is up 9% premarket on modest volume in response to the FDA granting Fast Track status for IMO-2125 for the …

OncoSec's ImmunoPulse shows durable treatment effect in mid-stage melanoma study; shares ahead 81% premarket

Nano cap OncoSec Medical (NASDAQ:ONCS) rockets 81% premarket on robust volume in response to positive long-term results from a Phase 2 clinical trial …